数字农科院2.0

Gut microbiota therapy in gastrointestinal diseases

文献类型： 外文期刊

作者： Ullah, Hanif;Arbab, Safia;Chang, Chengting;Bibi, Saira;Muhammad, Nehaz;Rehman, Sajid Ur;Suleman, Irfan;Ullah, Irfan;Ul Hassan, Inam;Tian, Yali;Li, Ka

作者机构：

关键词： gut microbiota;gastrointestinal diseases;cancer;therapy;dysbiosis

期刊名称： FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY

ISSN： 2296-634X

年卷期： 2025 年 13 卷

页码：

收录情况： SCIE（2025版）

摘要： The human gut microbiota, consisting of trillions of microorganisms, plays a crucial role in gastrointestinal (GI) health and disease. Dysbiosis, an imbalance in microbial composition, has been linked to a range of GI disorders, including inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, and colorectal cancer. These conditions are influenced by the interactions between the gut microbiota, the host immune system, and the gut-brain axis. Recent research has highlighted the potential for microbiome-based therapeutic strategies, such as probiotics, prebiotics, fecal microbiota transplantation (FMT), and dietary modifications, to restore microbial balance and alleviate disease symptoms. This review examines the role of gut microbiota in the pathogenesis of common gastrointestinal diseases and explores emerging therapeutic approaches aimed at modulating the microbiome. We discuss the scientific foundations of these interventions, their clinical effectiveness, and the challenges in their implementation. The review underscores the therapeutic potential of microbiome-targeted treatments as a novel approach to managing GI disorders, offering personalized and alternative options to conventional therapies. As research in this field continues to evolve, microbiome-based interventions hold promise for improving the treatment and prevention of gastrointestinal diseases.

分类号：

  • 相关文献

[1]Oncolytic virus and immunogenic cell death in cancer therapy. Cao, Guoxiu,Ding, Chan,Dai, Jun,Qiu, Xusheng. 2025

[2]Bt GS57 Interaction With Gut Microbiota Accelerates Spodoptera exigua Mortality. Li Y.,Zhao D.,Wu H.,Ji Y.,Liu Z.,Guo X.,Guo W.,Bi Y.. 2022

[3]Infection-Induced Intestinal Dysbiosis Is Mediated B.y Macrophage Activation And N itrate Production. Wang, S,El-Fahmawi, A,Christian, DA,Fang, Q,Radaelli, E,Chen, LF,Sullivan, MC,Misic, AM,Ellringer, JA,Zhu, XQ,Winter, SE,Hunter, CA,Beiting, DP. 2019

[4]Crosstalk between gut microbiota and host immune system and its response to traumatic injury. Ullah, Hanif,Arbab, Safia,Tian, Yali,Chen, Yuwen,Liu, Chang-qing,Li, Qijie,Li, Ka. 2024

[5]The Potential of Bile Acids as Biomarkers for Metabolic Disorders. Chang Yin,Ruqing Zhong,Weidong Zhang,Lei Liu,Liang Chen,Hongfu Zhang. 2023

[6]Exploring the Therapeutic Potential of Royal Jelly in Metabolic Disorders and Gastrointestinal Diseases. Hesham R. El-Seedi,Suzy Salama,Aida A.Abd El-Wahed,Zhiming Guo,Alessandro Di Minno,Maria Daglia,Chuan Li,Xiao Guan,Daniele Giuseppe Buccato,Shaden A.M. Khalifa,Kai Wang. 2024

[7]Association between intestinal microbiota and inflammatory bowel disease. Zhang, Yunchang,Si, Xuemeng,Yang, Ling,Wang, Hui,Sun, Ye,Liu, Ning. 2022

[8]MicroRNAs: Potentially important regulators for schistosome development and therapeutic targets against schistosomiasis. Cheng, Guofeng,Jin, Youxin,Jin, Youxin. 2012

[9]Coronavirus Infection and Cholesterol Metabolism. Jun Dai,Huan Wang,Ying Liao,Lei Tan,Yingjie Sun,Cuiping Song,Weiwei Liu,Xusheng Qiu,Chan Ding. 2022

[10]Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication. Shen, Wentao,Wang, Qian,Wang, Zhengxiang,Liu, Minxuan,Du, Yingying,Yuan, Lvfeng,Han, Lu,Smietanka, Krzysztof,Chen, Hualan,Xu, Shuai,Zhu, Qiyun. 2022

[11]A synthetic toll-like receptor 7 agonist inhibits porcine reproductive and respiratory syndrome virus replication in piglets. Qiuping Huang,Haoyan Yang,Dingfan Yang,Yuanjie Hao,Shijia Yu,Zhongyi Guo,Lingyujia Tian,Xuehui Cai,Baicheng Huang,Angke Zhang,Gang Wang,Taofeng Du. 2022

[12]Coronavirus Porcine Epidemic Diarrhea Virus Utilizes Chemokine Interleukin-8 to Facilitate Viral Replication by Regulating Ca2+ Flux. Guo, Xuyang,Feng, Yingtong,Zhao, Xiaojing,Qiao, Shuang,Ma, Zhiqian,Li, Zhiwei,Zheng, Haixue,Xiao, Shuqi. 2023

[13]Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy. Li, Hong,Liu, Tingli,Yang, Yongchun,Cho, William C.,Flynn, Robin J.,Harandi, Majid Fasihi,Song, Houhui,Luo, Xuenong,Zheng, Yadong. 2023

[14]Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies. Elfadadny A.,Ragab R.F.,AlHarbi M.,Badshah F.,Ibáñez-Arancibia E.,Farag A.,Hendawy A.O.,De los Ríos-Escalante P.R.,Aboubakr M.,Zakai S.A.,Nageeb W.M.. 2024

[15]Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation. Zheng, Jiangge,Lang, Yue,Zhang, Qi,Cui, Di,Sun, Haili,Jiang, Lun,Chen, Zhenhang,Zhang, Rui,Gao, Yina,Wu, Wei,Tang, Jun,Chen, Zhongzhou,Lang, Yue,Cui, Di,Sun, Haili,Zhang, Rui,Tang, Jun,Tian, Wenli.

[16]Human apo-SRP72 and SRP68/72 complex structures reveal the molecular basis of protein translocation. Gao, Yina,Liu, Yang,Dong, Xiaofei,Chen, Zhenhang,Tang, Jun,Wu, Wei,Chen, Zhongzhou,Zhang, Qi,Tong, Yufeng,Lang, Yue,Tang, Jun,Tian, Wenli,Tong, Yufeng.

[17]Recent Advances in Developing Photosensitizers for Photodynamic Cancer Therapy. Chen, Cong,Wang, Jianmin,Li, Xiaoyan,Chen, Cong,Wang, Jianmin,Li, Xiaoyan,Liu, Xiaolong,Liu, Xiaolong,Han, Xiao.

[18]The Coronin Family and Human Disease. Liu, Xiaolong,Gao, Yunzhen,Li, Lin,Liu, Jingfeng,Lin, Xiao,Li, Lin,Liu, Jingfeng,Han, Xiao.

[19]A review of recent studies in China on the possible beneficial health effects of tea. Zhu, YX,Huang, H,Tu, YY. 2006

[20]Tea and human health: biomedical functions of tea active components and current issues. Chen, Zong-mao,Lin, Zhi. 2015

作者其他论文 更多>>